These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15824825)

  • 1. [Markers of thrombophilia in patients with retinal vein thrombosis].
    Traipe L; Conte G; Conte FJ; Ibáñez S; Meza P; Rojas B; Cuneo M; Verdaguer J
    Rev Med Chil; 2005 Feb; 133(2):167-74. PubMed ID: 15824825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial thrombophilia and retinal vein occlusion.
    Backhouse O; Parapia L; Mahomed I; Lee D
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():13-7. PubMed ID: 10755093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of thrombophilia in retinal vein thrombosis.
    Hansen L; Kristensen HL; Bek T; Ingerslev J
    Acta Ophthalmol Scand; 2000 Oct; 78(5):523-6. PubMed ID: 11037907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.
    Janssen MC; den Heijer M; Cruysberg JR; Wollersheim H; Bredie SJ
    Thromb Haemost; 2005 Jun; 93(6):1021-6. PubMed ID: 15968383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age.
    Lahey JM; Tunç M; Kearney J; Modlinski B; Koo H; Johnson RN; Tanaka S
    Ophthalmology; 2002 Jan; 109(1):126-31. PubMed ID: 11772591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic thrombophilia in patients with retinal vascular occlusion.
    Greiner K; Peetz D; Winkgen A; Prellwitz W; Pfeiffer N; Hafner G
    Int Ophthalmol; 1999; 23(3):155-60. PubMed ID: 11456253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilic risk factors are uncommon in young patients with retinal vein occlusion.
    Ahluwalia J; Rao S; Varma S; Gupta A; Bose S; Masih J; Das R; Kumar N; Naseem S; Sharma P; Sachdeva MU; Varma N
    Retina; 2015 Apr; 35(4):715-9. PubMed ID: 25299970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombophilia - a risk factor of retinal vein occlusion?].
    Karska-Basta I; Kubicka-Trzaska A; Romanowska-Dixon B; Undas A
    Klin Oczna; 2013; 115(1):29-33. PubMed ID: 23882736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.
    Glueck CJ; Bell H; Vadlamani L; Gupta A; Fontaine RN; Wang P; Stroop D; Gruppo R
    Arch Ophthalmol; 1999 Jan; 117(1):43-9. PubMed ID: 9930159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion.
    Tekeli O; Gürsel E; Buyurgan H
    Acta Ophthalmol Scand; 1999 Dec; 77(6):628-30. PubMed ID: 10634552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance is a risk factor for central retinal vein occlusion.
    Marcucci R; Bertini L; Liotta AA; Rogolino A; Antonucci E; Ilari I; Pepe G; Prisco D
    Ann Ital Med Int; 2000; 15(3):195-8. PubMed ID: 11059059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic and cardiovascular risk factors for retinal vein occlusion.
    Bucciarelli P; Passamonti SM; Gianniello F; Artoni A; Martinelli I
    Eur J Intern Med; 2017 Oct; 44():44-48. PubMed ID: 28684050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
    Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
    Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion.
    Larsson J; Hillarp A; Olafsdottir E; Bauer B
    Acta Ophthalmol Scand; 1999 Dec; 77(6):634-7. PubMed ID: 10634554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilic factors in chronic thromboembolic pulmonary hypertension.
    Colorio CC; Martinuzzo ME; Forastiero RR; Pombo G; Adamczuk Y; Carreras LO
    Blood Coagul Fibrinolysis; 2001 Sep; 12(6):427-32. PubMed ID: 11555695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central retinal vein occlusion and thrombophilia risk factors.
    Adamczuk YP; Iglesias Varela ML; Martinuzzo ME; Cerrato GS; Forastiero RR
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):623-6. PubMed ID: 12439148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE.
    Liu Q; Lahey JM; Karlen R; Stewart JM
    Retina; 2018 Jun; 38(6):1175-1179. PubMed ID: 28613222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombophilia in systemic lupus erythematosus: A case-control study].
    Belfeki N; Khanfir MS; Said F; Houman MH
    J Med Vasc; 2018 Dec; 43(6):347-353. PubMed ID: 30522706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.